Search

everythinglearnresearchcommunity

for

Search:↓

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

A new method accurately measures cell changes in breast cancer.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Personalized, minimally invasive treatments improve urology outcomes.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.